Literature DB >> 28102081

Deep Coverage of Global Protein Expression and Phosphorylation in Breast Tumor Cell Lines Using TMT 10-plex Isobaric Labeling.

Fang-Ke Huang1, Guoan Zhang1, Kevin Lawlor2, Arpi Nazarian2, John Philip2, Paul Tempst2, Noah Dephoure3, Thomas A Neubert1.   

Abstract

Labeling peptides with isobaric tags is a popular strategy in quantitative bottom-up proteomics. In this study, we labeled six breast tumor cell lysates (1.34 mg proteins per channel) using 10-plex tandem mass tag reagents and analyzed the samples on a Q Exactive HF Quadrupole-Orbitrap mass spectrometer. We identified a total of 8,706 proteins and 28,186 phosphopeptides, including 7,394 proteins and 23,739 phosphosites common to all channels. The majority of technical replicates correlated with a R2 ≥ 0.98, indicating minimum variability was introduced after labeling. Unsupervised hierarchical clustering of phosphopeptide data sets successfully classified the breast tumor samples into Her2 (epidermal growth factor receptor 2) positive and Her2 negative groups, whereas mRNA abundance did not. The tyrosine phosphorylation levels of receptor tyrosine kinases, phosphoinositide-3-kinase, protein kinase C delta, and Src homology 2, among others, were significantly higher in the Her2 positive than the Her2 negative group. Despite ratio compression in MS2-based experiments, we demonstrated the ratios calculated using an MS2 method are highly correlated (R2 > 0.65) with ratios obtained using MS3-based quantitation (using a Thermo Orbitrap Fusion mass spectrometer) with reduced ratio suppression. Given the deep coverage of global and phosphoproteomes, our data show that MS2-based quantitation using TMT can be successfully used for large-scale multiplexed quantitative proteomics.

Entities:  

Keywords:  hierarchical clustering; mass spectrometry; phosphoproteomics; quantitative proteomics; tandem mass tag; titanium dioxide; tyrosine phosphorylation

Mesh:

Substances:

Year:  2017        PMID: 28102081      PMCID: PMC5336479          DOI: 10.1021/acs.jproteome.6b00374

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  42 in total

1.  Addressing accuracy and precision issues in iTRAQ quantitation.

Authors:  Natasha A Karp; Wolfgang Huber; Pawel G Sadowski; Philip D Charles; Svenja V Hester; Kathryn S Lilley
Journal:  Mol Cell Proteomics       Date:  2010-04-10       Impact factor: 5.911

2.  Biological sequence motif discovery using motif-x.

Authors:  Michael F Chou; Daniel Schwartz
Journal:  Curr Protoc Bioinformatics       Date:  2011-09

3.  The MaxQuant computational platform for mass spectrometry-based shotgun proteomics.

Authors:  Stefka Tyanova; Tikira Temu; Juergen Cox
Journal:  Nat Protoc       Date:  2016-10-27       Impact factor: 13.491

4.  Dysregulation of splicing proteins in head and neck squamous cell carcinoma.

Authors:  Aneesha Radhakrishnan; Vishalakshi Nanjappa; Remya Raja; Gajanan Sathe; Sandip Chavan; Raja Sekhar Nirujogi; Arun H Patil; Hitendra Solanki; Santosh Renuse; Nandini A Sahasrabuddhe; Premendu P Mathur; T S Keshava Prasad; Prashant Kumar; Joseph A Califano; David Sidransky; Akhilesh Pandey; Harsha Gowda; Aditi Chatterjee
Journal:  Cancer Biol Ther       Date:  2016-02-06       Impact factor: 4.742

5.  ShcA signalling is essential for tumour progression in mouse models of human breast cancer.

Authors:  Josie Ursini-Siegel; W Rod Hardy; Dongmei Zuo; Sonya H L Lam; Virginie Sanguin-Gendreau; Robert D Cardiff; Tony Pawson; William J Muller
Journal:  EMBO J       Date:  2008-02-14       Impact factor: 11.598

6.  Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips.

Authors:  Juri Rappsilber; Matthias Mann; Yasushi Ishihama
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

7.  GAREM, a novel adaptor protein for growth factor receptor-bound protein 2, contributes to cellular transformation through the activation of extracellular signal-regulated kinase signaling.

Authors:  Kyoko Tashiro; Takumi Tsunematsu; Hiroko Okubo; Takeshi Ohta; Etsuko Sano; Emiko Yamauchi; Hisaaki Taniguchi; Hiroaki Konishi
Journal:  J Biol Chem       Date:  2009-06-09       Impact factor: 5.157

8.  Neutron-encoded mass signatures for multiplexed proteome quantification.

Authors:  Alexander S Hebert; Anna E Merrill; Derek J Bailey; Amelia J Still; Michael S Westphall; Eric R Strieter; David J Pagliarini; Joshua J Coon
Journal:  Nat Methods       Date:  2013-02-24       Impact factor: 28.547

9.  Gas-phase purification enables accurate, multiplexed proteome quantification with isobaric tagging.

Authors:  Craig D Wenger; M Violet Lee; Alexander S Hebert; Graeme C McAlister; Douglas H Phanstiel; Michael S Westphall; Joshua J Coon
Journal:  Nat Methods       Date:  2011-10-02       Impact factor: 28.547

10.  MS3 eliminates ratio distortion in isobaric multiplexed quantitative proteomics.

Authors:  Lily Ting; Ramin Rad; Steven P Gygi; Wilhelm Haas
Journal:  Nat Methods       Date:  2011-10-02       Impact factor: 28.547

View more
  20 in total

1.  ProteoViz: a tool for the analysis and interactive visualization of phosphoproteomics data.

Authors:  Aaron J Storey; Kevin S Naceanceno; Renny S Lan; Charity L Washam; Lisa M Orr; Samuel G Mackintosh; Alan J Tackett; Rick D Edmondson; Zhengyu Wang; Hong-Yu Li; Brendan Frett; Samantha Kendrick; Stephanie D Byrum
Journal:  Mol Omics       Date:  2020-04-29

Review 2.  Recent advances in phosphoproteomics and application to neurological diseases.

Authors:  Justine V Arrington; Chuan-Chih Hsu; Sarah G Elder; W Andy Tao
Journal:  Analyst       Date:  2017-11-20       Impact factor: 4.616

Review 3.  Sample Multiplexing Strategies in Quantitative Proteomics.

Authors:  Albert B Arul; Renã A S Robinson
Journal:  Anal Chem       Date:  2018-12-18       Impact factor: 6.986

4.  Comparative Analysis of Quantitative Mass Spectrometric Methods for Subcellular Proteomics.

Authors:  Abla Tannous; Marielle Boonen; Haiyan Zheng; Caifeng Zhao; Colin J Germain; Dirk F Moore; David E Sleat; Michel Jadot; Peter Lobel
Journal:  J Proteome Res       Date:  2020-03-05       Impact factor: 4.466

5.  Poor maternal diet during gestation alters offspring muscle proteome in sheep.

Authors:  Sarah A Reed; Jeremy Balsbaugh; Xiaomeng Li; Timothy E Moore; Amanda K Jones; Sambhu M Pillai; Maria L Hoffman; Kristen E Govoni; Steven A Zinn
Journal:  J Anim Sci       Date:  2022-08-01       Impact factor: 3.338

6.  Quantitative Mass Spectrometry Normalization in Urine Biomarker Analysis in Nephrotic Syndrome.

Authors:  Timothy D Cummins; David W Powell; Daniel W Wilkey; Makayla Brady; Fredrick W Benz; Michelle T Barati; Dawn J Caster; Jon B Klein; Michael L Merchant
Journal:  Glomerular Dis       Date:  2022-01-27

7.  Proteomic Analysis and Biochemical Correlates of Mitochondrial Dysfunction after Low-Intensity Primary Blast Exposure.

Authors:  Hailong Song; Mei Chen; Chen Chen; Jiankun Cui; Catherine E Johnson; Jianlin Cheng; Xiaowan Wang; Russell H Swerdlow; Ralph G DePalma; Weiming Xia; Zezong Gu
Journal:  J Neurotrauma       Date:  2019-01-14       Impact factor: 5.269

Review 8.  Disease-specific interactome alterations via epichaperomics: the case for Alzheimer's disease.

Authors:  Stephen D Ginsberg; Thomas A Neubert; Sahil Sharma; Chander S Digwal; Pengrong Yan; Calin Timbus; Tai Wang; Gabriela Chiosis
Journal:  FEBS J       Date:  2021-06-12       Impact factor: 5.622

9.  2'-Hydroxyflavanone induced changes in the proteomic profile of breast cancer cells.

Authors:  Lokesh D Nagaprashantha; Jyotsana Singhal; Shireen Chikara; Gabriel Gugiu; David Horne; Sanjay Awasthi; Ravi Salgia; Sharad S Singhal
Journal:  J Proteomics       Date:  2018-09-21       Impact factor: 4.044

10.  Alternative Splicing of FN (Fibronectin) Regulates the Composition of the Arterial Wall Under Low Flow.

Authors:  Patrick A Murphy; Noor Jailkhani; Sarah-Anne Nicholas; Amanda M Del Rosario; Jeremy L Balsbaugh; Shahinoor Begum; Amy Kimble; Richard O Hynes
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-11-19       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.